Catalent Pharma Solutions Inc is categorized under Gelatin Capsules in Saint Petersburg, FL .
Catalent Pharma Solutions Inc was established in 0, and today employs 1 to 4, earning $500.000.000 to $999.999.999 per year. This is a Gelatin Capsules business, which does work in the B2B market, and is classified as a Gelatin Capsules, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Peter Beke, Manager at the company’s branch by writing to 2725 Scherer Drive North, Saint Petersburg, Florida FL 33716 or by phoning (727) 572-4000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Catalent Pharma Solutions Inc |
| Contact Person: | Peter Beke, Manager |
| Address: | 2725 Scherer Drive North, Saint Petersburg, Florida 33716 |
| Phone Number: | (727) 572-4000 |
| Website Address: | catalent.com |
| Annual Revenue (USD): | $500.000.000 to $999.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Gelatin Capsules |
| SIC Code: | 2899 |
| NAICS Code: | 3254120 |
| Share This Business: |
Catalent Pharma Solutions Inc was started in 0 to provide professional Gelatin Capsules under the SIC code 2899 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000.000 to $999.999.999 per annum.
Feel free to contact Peter Beke, Manager for inquiries that concern Catalent Pharma Solutions Inc by calling the company number (727) 572-4000, as your correspondence is most welcome. Additionally, the physical location of the branch of Catalent Pharma Solutions Inc can be found at the coordinates 27.88563,-82.67335 as well as the street address 2725 Scherer Drive North in Saint Petersburg, Florida 33716.
For its online presence, you may visit Catalent Pharma Solutions Inc’s website at catalent.com and engage with its social media outlets through on Twitter and on Facebook.